Kim Steegen

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Venues

Viruses

The Journal of antimicrobial chemotherapy

Journal of the International AIDS Society

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kim Steegen, Gert U van Zyl, Mathilda Claassen, Aabida Khan, Melendhran Pillay, Subitha Govender, Phillip A Bester, Johanna M van Straaten, Vibha Kana, Ewaldé Cutler, Monalisa N Kalimashe, Ramokone Lisbeth Lebelo, Mokopi B H Moloi, Lucia Hans
Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa's Experience and Future Directions for Resource-Limited Settings. Diagnostics (Basel, Switzerland) 13 (13) (2023)
Gillian M Hunt, Mukhlid Yousif, Leon Levin, Johanna Ledwaba, Kim Steegen, Tendesayi Kufa, Hloniphile Zwane, Monalisa Kalimashe, Vibha Kana, Getahun Aynalem, Jaclyn Perlman, Kassahun Ayalew, Gurpreet Kindra, Karidia Diallo, Sergio Carmona, Gayle Sherman, Elliot J Raizes
Resistance is common in paediatric patients failing ART in South Africa. The Journal of antimicrobial chemotherapy (2023)
Seth C Inzaule, Mark J Siedner, Susan J Little, Santiago Avila-Ríos, Alisen Ayitewala, Ronald J Bosch, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Diane Descamps, Susan H Eshleman, Joseph Fokam, Lisa M Frenkel, Ravindra K Gupta, John P A Ioannidis, Pontiano Kaleebu, Rami Kantor, Seble G Kassaye, Sergei L Kosakovsky Pond, Vinie Kouamou, Roger D Kouyos, Daniel R Kuritzkes, Richard J Lessells, Anne-Genevieve Marcelin, Stefan D Baral, Brian Minalga, Nicaise Ndembi, Richard A Neher, Roger Paredes, Deenan Pillay, Elliot G Raizes, Soo-Yon Rhee, Douglas D Richman, Kiat Ruxrungtham, Pardis C Sabeti, Jonathan M Schapiro, Sunee Sirivichayakul, Kim Steegen, Wataru Sugiura, Gert U van Zyl, Anne-Mieke Vandamme, Annemarie M J Wensing, Joel O Wertheim, Huldrych F Gunthard, Michael R Jordan, Robert W Shafer
Recommendations on data sharing in HIV drug resistance research. PLoS medicine 20 (9) (2023)
Hope Kanise, Joep J van Oosterhout, Pachawo Bisani, John Songo, Bilaal W Matola, Chifundo Chipungu, Katherine Simon, Carrie M Cox, Mina C Hosseinipour, Jean-Batiste Sagno, Risa M Hoffman, Claudia Wallrauch, Sam Phiri, Kim Steegen, Andreas Jahn, Rose Nyirenda, Tom Heller
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses 16 (1) (2023)
Hope Kanise, Joep J van Oosterhout, Pachawo Bisani, John Songo, Bilaal W Matola, Chifundo Chipungu, Katherine Simon, Carrie M Cox, Mina C Hosseinipour, Jean-Batiste Sagno, Risa M Hoffman, Claudia Wallrauch, Sam Phiri, Kim Steegen, Andreas Jahn, Rose Nyirenda, Tom Heller
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses 16 (1) (2023)
Hope Kanise, Joep J van Oosterhout, Pachawo Bisani, John Songo, Bilaal W Matola, Chifundo Chipungu, Katherine Simon, Carrie M Cox, Mina C Hosseinipour, Jean-Batiste Sagno, Risa M Hoffman, Claudia Wallrauch, Sam Phiri, Kim Steegen, Andreas Jahn, Rose Nyirenda, Tom Heller
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses 16 (1) (2023)
Hope Kanise, Joep J van Oosterhout, Pachawo Bisani, John Songo, Bilaal W Matola, Chifundo Chipungu, Katherine Simon, Carrie M Cox, Mina C Hosseinipour, Jean-Batiste Sagno, Risa M Hoffman, Claudia Wallrauch, Sam Phiri, Kim Steegen, Andreas Jahn, Rose Nyirenda, Tom Heller
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses 16 (1) (2023)
Hope Kanise, Joep J van Oosterhout, Pachawo Bisani, John Songo, Bilaal W Matola, Chifundo Chipungu, Katherine Simon, Carrie M Cox, Mina C Hosseinipour, Jean-Batiste Sagno, Risa M Hoffman, Claudia Wallrauch, Sam Phiri, Kim Steegen, Andreas Jahn, Rose Nyirenda, Tom Heller
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses 16 (1) (2023)
Kim Steegen, Leon J Levin, Denise Evans, Karl-Gunter Technau, Lucia Hans
Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment. The Pediatric infectious disease journal 41 (10) (2022)
Johannes C Botha, Kim Steegen, Mariam Edoo, Jeremy S Nel, Gert U van Zyl
Low-level viraemia despite emergence of dolutegravir-resistant variants. Southern African journal of HIV medicine 23 (1) (2022)
Avania Bangalee, Lucia Hans, Kim Steegen
Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa. The Journal of antimicrobial chemotherapy 76 (10) (2021)
Kim Steegen, Michelle Moorhouse, Annemarie M J Wensing, Willem Df Venter, Lucia Hans
Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa. Journal of the International AIDS Society 24 (5) (2021)

Kim Steegen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kim Steegen